Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Biol Reprod ; 62(6): 1710-21, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10819775

RESUMO

The purpose of this study was to identify factors from astrocytes that can regulate LHRH neurosecretion. Exposure of LHRH-secreting (GT1-7) cells to conditioned media (CM) from C6 glial cells and hypothalamic astrocytes (HA) stimulated LHRH release. Assays of C6 and HA CM revealed that transforming growth factor-beta(1) (TGF-beta(1)) and 3alpha-hydroxy-5alpha-pregnane-20-one (3alpha, 5alpha-THP), both known LHRH secretagogues, were present in CM and their levels increased in parallel to the LHRH-releasing activity of CM. In contrast, TGF-alpha was undetectable in C6 or HA CM. Ultrafiltration to remove peptides with molecular weights >10 kDa virtually abolished the LHRH-releasing ability of the HA CM. Furthermore, immunoneutralization with a panspecific THF-beta antibody dose-dependently attenuated the LHRH-releasing activity of the CM. Rat hypothalamus and GT1-7 cells were demonstrated to express TGF-beta receptors as well as furin, an enzyme that converts latent TGF-beta(1) to active TGF-beta(1). Estrogen receptor-alpha and ER-beta mRNA and protein were also demonstrated in HAs by reverse transcription-polymerase chain reaction and double immunofluorescence, and treatment with 17beta-estradiol (17beta-E(2)) increased both active and latent TGF-beta(1) levels in HA CM. The effect of 17beta-E(2) was completely blocked by the ER antagonist ICI8280. As a whole, these studies provide evidence of a previously undescribed 17beta-E(2)-TGF-beta(1)-LHRH signaling pathway.


Assuntos
Astrócitos/metabolismo , Meios de Cultivo Condicionados , Estradiol/farmacologia , Hormônio Liberador de Gonadotropina/metabolismo , Fator de Crescimento Transformador beta/fisiologia , Animais , Anticorpos/farmacologia , Linhagem Celular , Linhagem Celular Transformada , Meios de Cultivo Condicionados/química , Imunofluorescência , Hipotálamo/citologia , Neuroglia/metabolismo , Pregnanolona/análogos & derivados , Pregnanolona/análise , Pregnanolona/farmacologia , Ratos , Fator de Crescimento Transformador beta/análise , Fator de Crescimento Transformador beta/farmacologia , Ultrafiltração
2.
Mol Cell ; 7(4): 705-13, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11336695

RESUMO

Checkpoint controls coordinate entry into mitosis with the completion of DNA replication. Depletion of nucleotide precursors by treatment with the drug hydroxyurea triggers such a checkpoint response. However, it is not clear whether the signal for this hydroxyurea-induced checkpoint pathway is the presence of unreplicated DNA, or rather the persistence of single-stranded or damaged DNA. In a yeast artificial chromosome (YAC) we have engineered an approximately 170 kb region lacking efficient replication origins that allows us to explore the specific effects of unreplicated DNA on cell cycle progression. Replication of this YAC extends the length of S phase and causes cells to engage an S/M checkpoint. In the absence of Rad9 the YAC becomes unstable, undergoing deletions within the origin-free region.


Assuntos
Cromossomos Artificiais de Levedura/fisiologia , Genes cdc/fisiologia , Mitose/genética , Proteínas Serina-Treonina Quinases , Origem de Replicação/genética , Fase S/genética , Proteínas de Saccharomyces cerevisiae , Proteínas de Ciclo Celular/genética , Quinase do Ponto de Checagem 2 , Dano ao DNA/genética , Replicação do DNA/genética , Deleção de Genes , Genes Fúngicos/fisiologia , Hidroxiureia , Inibidores da Síntese de Ácido Nucleico , Fosforilação , Proteínas Quinases/genética , Proteínas Quinases/metabolismo , Saccharomyces cerevisiae
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA